The pathogenesis of measles

Current Opinion in Virology

Volumn 2, Issue 3, 2012, Pages 248-255

  De Vries, Rory D ^a   Mesman, Annelies W ^b   Geijtenbeek, Teunis B H ^b   Duprex, W Paul ^c   De Swart, Rik L ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD150 ANTIGEN; CELL RECEPTOR; NECTIN 4; PROTEIN; UNCLASSIFIED DRUG;

AIRWAY; CELL ADHESION; CELL DAMAGE; DENDRITIC CELL; HUMAN; LUNG ALVEOLUS MACROPHAGE; LYMPHOID TISSUE; MEASLES; MEASLES VIRUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY TRACT MUCOSA; REVIEW; SYSTEMIC DISEASE; TARGET CELL; VIREMIA; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANIMALS; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; HUMANS; LYMPH NODES; LYMPHOCYTES; MACROPHAGES; MEASLES; MEASLES VIRUS; RECEPTORS, VIRUS; RESPIRATORY SYSTEM; VIREMIA; VIRUS INTERNALIZATION;

EID: 84862881326     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2012.03.005     Document Type: Review

References (75)

1. WHO: Global reductions in measles mortality 2000-2008 and the risk of measles resurgence. Wkly Epidemiol Rec 2009, 84:509-516.
2. Griffin DE: Measles virus. In Fields Virology, edn 5. Edited by Knipe DM, Howley PM. Philadelphia: Lippincott Williams & Wilkins; 2007:1551-1585.
3. Duke T, Mgone CS: Measles: not just another viral exanthem. Lancet 2003, 361:763-773. (Pubitemid 36293634)
4. Esolen LM, Ward BJ, Moench TR, Griffin DE: Infection of monocytes during measles. J Infect Dis 1993, 168:47-52. (Pubitemid 23178728)
5. Rima BK, Duprex WP: Morbilliviruses and human disease. J Pathol 2006, 208:199-214. (Pubitemid 43126113)
6. Naniche D, Varior-Krishnan G, Cervoni F, Wild TF, Rossi B, Rabourdin-Combe C, Gerlier D: Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 1993, 67:6025-6032. (Pubitemid 23277513)
7. Dörig RE, Marcil A, Chopra A, Richardson CD: The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 1993, 75:295-305. (Pubitemid 23320293)
8. Buckland R, Wild TF: Is CD46 the cellular receptor for measles virus? Virus Res 1997, 48:1-9. (Pubitemid 27163263)
9. De Vries RD, Lemon K, Ludlow M, McQuaid S, Yüksel S, Van Amerongen G, Rennick LJ, Rima BK, Osterhaus ADME, De Swart RL, Duprex WP: In vivo tropism of attenuated and pathogenic measles virus expressing green fluorescent protein in macaques. J Virol 2010, 84:4714-4724.
10. Takeuchi K, Nagata N, Kato SI, Ami Y, Suzaki Y, Suzuki T, Sato Y, Tsunetsugu-Yokota Y, Mori K, Van N, Guyen N et al.: Wild-type measles virus with the hemagglutinin protein of the Edmonston vaccine strain retains wild-type tropism in macaques. J Virol 2012, 86:3027-3037.
11. Tatsuo H, Ono N, Tanaka K, Yanagi Y: SLAM (CDw150) is a cellular receptor for measles virus. Nature 2000, 406:893-897. (Pubitemid 30664265)
12. Yanagi Y, Takeda M, Ohno S, Seki F: Measles virus receptors and tropism. Jpn J Infect Dis 2006, 59:1-5.
13. Tatsuo H, Ono N, Yanagi Y: Morbilliviruses use signaling lymphocyte activation molecules (CD150) as cellular receptors. J Virol 2001, 75:5842-5850. (Pubitemid 32553114)
14. Von Messling V, Svitek N, Cattaneo R: Receptor (SLAM [CD150]) recognition and the V protein sustain swift lymphocyte-based invasion of mucosal tissue and lymphatic organs by a morbillivirus. J Virol 2006, 80:6084-6092. (Pubitemid 43849186)
15. Leonard VH, Hodge G, Reyes-del Valle J, McChesney MB, Cattaneo R: Measles virus selectively blind to signaling lymphocytic activation molecule (SLAM; CD150) is attenuated and induces strong adaptive immune responses in rhesus monkeys. J Virol 2010, 84:3413-3420.
16. Cocks BG, Chang CC, Carballido JM, Yssel H, De Vries JE, Aversa G: A novel receptor involved in T-cell activation. Nature 1995, 376:260-263.
17. + dendritic cells and is up-regulated by IL-1beta. J Immunol 2001, 167:1989-1995.
18. McQuaid S, Cosby SL: An immunohistochemical study of the distribution of the measles virus receptors, CD46 and SLAM, in normal human tissues and subacute sclerosing panencephalitis. Lab Invest 2002, 82:403-409. (Pubitemid 34311113)
19. Sidorenko SP, Clark EA: Characterization of a cell surface glycoprotein IPO-3, expressed on activated human B and T lymphocytes. J Immunol 1993, 151:4614-4624. (Pubitemid 23318515)
20. Veillette A: NK cell regulation by SLAM family receptors and SAP-related adapters. Immunol Rev 2006, 214:22-34.
21. Van der Vlist M, De Witte L, De Vries RD, Litjens M, de Jong MAWP, Fluitsma D, De Swart RL, Geijtenbeek TBH: Human Langerhans cells capture measles virus through Langerin and present viral antigens to CD4(+) T-cells but are incapable of cross-presentation. Eur J Immunol 2011, 41:2619-2631.Description of Langerin on Langerhans cells (LC) as an MV attachment receptor, analogous to DC-SIGN.
22. +lymphocytes and dendritic cells during measles virus infection of macaques. PLoS Pathog 2007, 3:e178.
23. Moench TR, Griffin DE, Obriecht CR, Vaisberg AJ, Johnson RT: Acute measles in patients with and without neurological involvement: distribution of measles virus antigen and RNA. J Infect Dis 1988, 158:433-442.
24. Andres O, Obojes K, Kim KS, Ter Meulen V, Schneider- Schaulies J: CD46- and CD150-independent endothelial cell infection with wild-type measles viruses. J Gen Virol 2003, 84:1189-1197. (Pubitemid 36603297)
25. Takeuchi K, Miyajima N, Nagata N, Takeda M, Tashiro M: Wild-type measles virus induces large syncytium formation in primary human small airway epithelial cells by a SLAM(CD150)- independent mechanism. Virus Res 2003, 94:11-16. (Pubitemid 36776741)
26. Takeda M, Tahara M, Hashiguchi T, Sato TA, Jinnouchi F, Ueki S, Ohno S, Yanagi Y: A human lung carcinoma cell line supports efficient measles virus growth and syncytium formation via SLAM- and CD46-independent mechanism. J Virol 2007, 81:12091-12096. (Pubitemid 47623842)
27. Tahara M, Takeda M, Shirogane Y, Hashiguchi T, Ohno S, Yanagi Y: Measles virus infects both polarized epithelial and immune cells using distinctive receptor-binding sites on its hemagglutinin. J Virol 2008, 82:4630-4637. (Pubitemid 351563699)
28. Ludlow M, Rennick L, Sarlang S, Skibinski G, McQuaid S, Moore T, De Swart RL, Duprex WP: Wild-type measles virus infection of primary epithelial cells occurs via the basolateral surface without syncytium formation or release of infectious virus. J Gen Virol 2010, 91:971-979.
29. Noyce RS, Bondre DG, Ha MN, Lin LT, Sisson G, Tsao MS, Richardson CD: Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus. PLoS Pathog 2011, 7:e1002240. Discovery of Nectin-4 as a cellular receptor for MV on epithelial cells.
30. Mühlebach MD, Mateo M, Sinn PL, Prufer S, Uhlig KM, Leonard VHJ, Navaratnarajah CK, Frenzke M, Wong XX, Sawatsky B et al.: Adherens junction protein nectin-4 is the epithelial receptor for measles virus. Nature 2011. Discovery of Nectin-4 as a cellular receptor for MV on epithelial cells.
31. De Witte L, Abt M, Schneider-Schaulies S, van Kooyk Y, Geijtenbeek TBH: Measles virus targets DC-SIGN to enhance dendritic cell infection. J Virol 2006, 80:3477-3486.
32. De Witte L, De Vries RD, Van der Vlist M, Yüksel S, Litjens M, De Swart RL, Geijtenbeek TBH: DC-SIGN and CD150 have distinct roles in transmission of measles virus from dendritic cells to T-lymphocytes. PLoS Pathog 2008, 4:e1000049.
33. Geijtenbeek TBH, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, Middel J, Cornelissen IL, Nottet HS, KewalRamani VN, Littman DR et al.: DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000, 100:587-597.
34. De Witte L, Nabatov A, Pion M, Fluitsma D, De Jong MAWP, de Gruijl T, Piguet V, van Kooyk Y, Geijtenbeek TBH: Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat Med 2007, 13:367-371.
35. de Jong MAWP, Geijtenbeek TBH: Langerhans cells in innate defense against pathogens. Trends Immunol 2010, 31:452-459.
36. Gringhuis SI, Van der Vlist M, van den Berg LM, Den Dunnen J, Litjens M, Geijtenbeek TB: HIV-1 exploits innate signaling by TLR8 and DC-SIGN for productive infection of dendritic cells. Nat Immunol 2010, 11:419-426. Study that elucidates the necessity of DC-SIGN signaling for HIV-1 to establish a productive infection in DC.
37. Sellin CI, Horvat B: Current animal models: transgenic animal models for the study of measles pathogenesis. Curr Top Microbiol Immunol 2009, 330:111-127.
38. Pillet S, Svitek N, von Messling V: Ferrets as a model for morbillivirus pathogenesis, complications, and vaccines. Curr Top Microbiol Immunol 2009, 330:73-87.
39. Niewiesk S: Current animal models: cotton rat animal model. Curr Top Microbiol Immunol 2009, 330:89-110.
40. Anderson JF, Goldberger J: Experimental measles in the monkey: a supplemental note. Publ Health Rep 1911, 26:887-895.
41. Van Binnendijk RS, van der Heijden RWJ, Van Amerongen G, UytdeHaag FGCM, Osterhaus ADME: Viral replication and development of specific immunity in macaques after infection with different measles virus strains. J Infect Dis 1994, 170:443-448. (Pubitemid 24226379)
42. Kobune F, Takahashi H, Terao K, Ohkawa T, Ami Y, Suzaki Y, Nagata N, Sakata H, Yamanouchi K, Kai C: Nonhuman primate models of measles. Lab Anim Sci 1996, 46:315-320. (Pubitemid 126492188)
43. McChesney MB, Miller CJ, Rota PA, Zhu Y, Antipa L, Lerche NW, Ahmed R, Bellini WJ: Experimental measles. I. Pathogenesis in the normal and the immunized host. Virology 1997, 233:74-84. (Pubitemid 27348769)
44. De Swart RL: Measles studies in the macaque model. Curr Top Microbiol Immunol 2009, 330:55-72.
45. Remfry J: A measles epizootic with 5 deaths in newly-imported rhesus monkeys (Macaca mulatta). Lab Anim 1976, 10:49-57.
46. Hashimoto K, Ono N, Tatsuo H, Minagawa H, Takeda M, Takeuchi K, Yanagi Y: SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein. J Virol 2002, 76:6743-6749. (Pubitemid 34633540)
47. Ludlow M, Duprex WP, Cosby SL, Allen IV, McQuaid S: Advantages of using recombinant measles viruses expressing a fluorescent reporter gene with vibratome slice technology in experimental measles neuropathogenesis. Neuropathol Appl Neurobiol 2008, 34:424-434.
48. Rota PA, Featherstone DF, Bellini WJ: Molecular epidemiology of measles virus. Curr Top Microbiol Immunol 2009, 330:129-150.
49. Leonard VHJ, Sinn PL, Hodge G, Miest T, Devaux P, Oezguen N, Braun W, McCray PB, McChesney MB, Cattaneo R: Measles virus blind to its epithelial cell receptor remains virulent in rhesus monkeys but cannot cross the airway epithelium and is not shed. J Clin Invest 2008, 118:2448-2458. (Pubitemid 351949773)
50. Lemon K, De Vries RD, Mesman AW, McQuaid S, Van Amerongen G, Yüksel S, Ludlow M, Rennick LJ, Kuiken T, Rima BK et al.: Early target cells of measles virus after aerosol infection of non-human primates. PLoS Pathog 2011, 7:e1001263. Elucidation of the initial target cells targeted by MV in non-human primates, after infection via aerosol inhalation.
51. Ferreira CS, Frenzke M, Leonard VHJ, Welstead GG, Richardson CD, Cattaneo R: Measles virus infection of alveolar macrophages and dendritic cells precedes spread to lymphatic organs in transgenic mice expressing human signaling lymphocytic activation molecule (SLAM: CD150). J Virol 2010, 84:3033-3042.
52. Lessler J, Reich NG, Brookmeyer R, Perl TM, Nelson KE, Cummings DA: Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis 2009, 9:291-300.
53. Hall WC, Kovatch RM, Herman PH, Fox JG: Pathology of measles in rhesus monkeys. Vet Pathol 1971, 8:307-319.
54. Sakaguchi M, Yoshikawa Y, Yamanouchi K, Sata T, Nagashima K, Takeda K: Growth of measles virus in epithelial and lymphoid tissues of cynomolgus monkeys. Microbiol Immunol 1986, 30:1067-1073. (Pubitemid 17206735)
55. Warthin AS: Occurrence of numerous large giant cells in the tonsils and pharyngeal mucosa in the prodromal stage of measles. Arch Pathol 1931, 11:864-874.
56. Finkeldey W: Über Riesenzellbefunde in den Gaumenmandeln, zugleich ein Beitrag zur Histopathologie der Mandelveränderungen im Maserninkubationsstadium. Virchows Arch 1931, 281:323-329.
57. + T-lymphocytes control dissemination of measles virus. Eur J Immunol 2010, 40:388-395.
58. Beckford AP, Kaschula RO, Stephen C: Factors associated with fatal cases of measles. A retrospective autopsy study. S Afr Med J 1985, 68:858-863. (Pubitemid 16177108)
59. Akramuzzaman SM, Cutts FT, Wheeler JG, Hossain MJ: Increased childhood morbidity after measles is short-term in urban Bangladesh. Am J Epidemiol 2000, 151:723-735. (Pubitemid 30463594)
60. Shanks GD, Lee SE, Howard A, Brundage JF: Extreme mortality after first introduction of measles virus to the polynesian island of Rotuma, 1911. Am J Epidemiol 2011, 173:1211-1222. Describes the main causes of mortality in a first introduction of measles in an isolated population.
61. Von Pirquet CE: Das Verhalten der kutanen Tuberkulin-reaktion während der Masern. Dtsch Med Wochenschr 1908, 34:1297-1300.
62. Tamashiro VG, Perez HH, Griffin DE: Prospective study of the magnitude and duration of changes in tuberculin reactivity during uncomplicated and complicated measles. Pediatr Infect Dis J 1987, 6:451-454. (Pubitemid 17072087)
63. Ryon JJ, Moss WJ, Monze M, Griffin DE: Functional and phenotypic changes in circulating lymphocytes from hospitalized Zambian children with measles. Clin Diagn Lab Immunol 2002, 9:994-1003. (Pubitemid 34988465)
64. Premenko-Lanier M, Rota PA, Rhodes GH, Bellini WJ, McChesney MB: Protection against challenge with measles virus (MV) in infant macaques by an MV DNA vaccine administered in the presence of neutralizing antibody. J Infect Dis 2004, 189:2064-2071. (Pubitemid 38692287)
65. Bankamp B, Hodge G, McChesney MB, Bellini WJ, Rota PA: Genetic changes that affect the virulence of measles virus in a rhesus macaque model. Virology 2008, 373:39-50.
66. Hirsch RL, Griffin DE, Johnson RT, Cooper SJ, Lindo de Soriano I, Roedenbeck S, Vaisberg A: Cellular immune responses during complicated and uncomplicated measles virus infections of man. Clin Immunol Immunopathol 1984, 31:1-12. (Pubitemid 14168274)
67. Ward BJ, Johnson RT, Vaisberg A, Jauregui E, Griffin DE: Cytokine production in vitro and the lymphoproliferative defect of natural measles virus infection. Clin Immunol Immunopathol 1991, 61:236-248.
68. Avota E, Avots A, Niewiesk S, Kane LP, Bommhardt U, ter MV, Schneider-Schaulies S: Disruption of Akt kinase activation is important for immunosuppression induced by measles virus. Nat Med 2001, 7:725-731. (Pubitemid 32588030)
69. Griffin DE, Ward BJ: Differential CD4 T cell activation in measles. J Infect Dis 1993, 168:275-281. (Pubitemid 23210599)
70. Fugier-Vivier I, Servet-Delprat C, Rivailler P, Rissoan M-C, Liu Y-J, Rabourdin-Combe C: Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells. J Exp Med 1997, 186:813-823. (Pubitemid 27407343)
71. Grosjean I, Caux C, Bella C, Berger I, Wild F, Banchereau J, Kaiserlian D: Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4+ T cells. J Exp Med 1997, 186:801-812. (Pubitemid 27407342)
72. Schnorr J-J, Xanthakos S, Keikavoussi P, Kampgen E, Ter Meulen V, Schneider-Schaulies S: Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immmunosuppression. Proc Natl Acad Sci U S A 1997, 94:5326-5331. (Pubitemid 27214782)
73. Condack C, Grivel J-C, Devaux P, Margolis L, Cattaneo R: Measles virus vaccine attenuation: suboptimal infection of lymphatic tissue and tropism alteration. J Infect Dis 2007, 196:541-549. (Pubitemid 47206100)
74. Racaniello V: An exit strategy for measles virus. Science 2011, 334:1650-1651. Recent review of the potential role of the newly described cellular entry receptor nectin-4 in MV transmission.
75. Ludlow M, Allen I, Schneider-Schaulies J: Systemic spread of measles virus: overcoming the epithelial and endothelial barriers. Thromb Haemost 2009, 102:1050-1056.